Portal
Home
REMICADE®
(infliximab)
PROCRIT®
(Epoetin alfa)
DOXIL®
(doxorubicin HCl liposome injection)
SIMPONI®
(golimumab)
STELARA®
(ustekinumab)
ZYTIGA®
(abiraterone acetate)
XARELTO®
(rivaroxaban tablets)
Janssen Biotech, Inc.
Introduction Prior Authorization Please see full Prescribing Information, including Boxed WARNINGS,
for PROCRIT®
(Epoetin alfa)
Medicare Guideline Archives Medicare Guideline Update Table CMS 1450 / UB-04

State Medicare Guidelines / CMS 1500
Select


PROCRIT® BILLING

Medicare Administrative Contractor (MAC) Jurisdictions Information

The Centers for Medicare & Medicaid Services (CMS) is integrating the administration of Medicare Parts A and B for the fee-for-service benefit to new entities called Medicare Administrative Contractors (MACs). To learn more about the status of this program in your state, click on your state in the map below, or select your state from the drop down menu, or visit the CMS Web site.


The information provided presents no statement, promise, or guarantee by Janssen Biotech, Inc., concerning levels of reimbursement, payment, or charge. Please consult your payer organizations with regard to local or actual coverage and reimbursement policies and determination processes.